Have you or a loved one experienced serious side effects, including cancer, after taking Belviq for weight loss?
You may be entitled to a Significant Compensation.
The FDA has issued a warning against Belviq due to the possibility of dangerous side effects from taking this drug.
Get Your Free Case Evaluation Today.
By clicking the “SEE IF I QUALIFY” button above, you agree that you will be contacted by telephone, email SMS/Text Message (Data Rates May Apply), even if you are on a federal or state Do Not Call registry, to confirm the accuracy of the information you submit and verify if you qualify.
Belviq (lorcaserin), is a drug prescribed to treat obesity. It was also prescribed to those who had serious weight-related health conditions including diabetes and high blood pressure.
Belviq is manufacturered by Arena Pharmaceuticals, based in Switzerland. The drug is marketed and distributed in the United States by Eisai, Inc.
FDA Requests Withdrawal
On February 13, 2020, the US Food and Drug Administration requested that the manufacturer of Belviq/Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer.